Literature DB >> 2037868

Protein ligand interactions:isoquinoline alkaloids as inhibitors for lactate and malate dehydrogenase.

E Kapp1, C Whiteley.   

Abstract

Kinetic analysis has shown that isoquinoline, papaverine and berberine act as reversible competitive inhibitors to muscle lactate dehydrogenase and mitochondrial malate dehydrogenase with respect to the coenzyme NADH. The inhibitor constants Ki vary from 7.5 microM and 12.6 microM berberine interaction with malate dehydrogenase and lactate dehydrogenase respectively to 91.4 microM and 196.4 microM with papaverine action on these two enzymes. Isoquinoline was a poor inhibitor with Ki values of 200 microM (MDH) to 425 microM (LDH). No inhibition was observed for both enzymes in terms of their respective second substrate (oxaloacetic acid - malate dehydrogenase; pyruvate - lactate dehydrogenase). A fluorimetric analysis of the binding of the three alkaloids show that the dissociation constants (Kd) for malate dehydrogenase are 2.8 microM (berberine), 46 microM (papaverine) and 86 microM (isoquinoline); the corresponding values for lactate dehydrogenase are 3.1 microM, 52 microM and 114 microM. In all cases the number of binding sites averaged at 2 (MDH) and 4 (LDH). The binding of the alkaloids takes place at sites close to the coenzyme binding site. No conformational non equivalence of subunits is evident.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2037868     DOI: 10.3109/14756369109035847

Source DB:  PubMed          Journal:  J Enzyme Inhib        ISSN: 1026-5457


  2 in total

1.  Optimization of a non-radioactive high-throughput assay for decarboxylase enzymes.

Authors:  David C Smithson; Anang A Shelat; Jeffrey Baldwin; Margaret A Phillips; R Kiplin Guy
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

Review 2.  Natural products targeting human lactate dehydrogenases for cancer therapy: A mini review.

Authors:  Huankai Yao; Feng Yang; Yan Li
Journal:  Front Chem       Date:  2022-09-29       Impact factor: 5.545

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.